Document is current
Any future updates will be listed below
-
Authors
Ryan, Karen M. https://orcid.org/0000-0002-9264-8757
Smyth, Paul
Blackshields, Gordon https://orcid.org/0000-0003-2114-9958
Kranaster, Laura https://orcid.org/0000-0002-8414-0910
Sartorius, Alexander https://orcid.org/0000-0002-1243-3693
Sheils, Orla https://orcid.org/0000-0002-4493-9496
McLoughlin, Declan M. https://orcid.org/0000-0003-4574-2799
-
Funding
Funding for this research was provided by:
Brain and Behavior Research Foundation (22516)
Health Research Board (TRA/2007/5, HPF/2010/17)
- License Information
-
More Information
Article History
Received: 18 August 2022
Accepted: 9 November 2022
First Online: 22 November 2022
Declarations
:
: Experimental procedures with animals were approved by the Bioresources Ethics Committee, Trinity College Dublin and were in compliance with the European Council Directive (86/609/EEC). Ethical approval for the human portion of this study was granted by the St Patrick’s University Hospital Research Ethics Committee in Dublin (Protocol No. 012/07) and the local ethics committee in Mannheim, Germany. The human studies were performed in accordance with the Declaration of Helsinki.
: Written informed consent was obtained from all individual participants included in the study.
: Not applicable.
: DMM has received speaker’s honoraria from MECTA and Otsuka and an honorarium from Janssen for participating in an esketamine advisory board meeting. KR, LK, AS, PS, GB, and OS have no competing interests to declare.
